Data gathered: April 5
AI Stock Analysis - RxSight (RXST)
Analysis generated March 29, 2025. Powered by Chat GPT.
RxSight is a medical device company focused on developing innovative intraocular lens (IOL) systems for cataract surgery. The company's primary product, the Light Adjustable Lens (LAL), utilizes a proprietary technology that allows post-surgical adjustments to correct visual results. This unique feature distinguishes RxSight in the ophthalmic market, addressing an essential need for customizable vision correction that traditional IOLs cannot meet.
Stock Alerts - RxSight (RXST)
 |
RxSight | April 4 Price is down by -6.5% in the last 24h. |
|
RxSight | April 3 Price is down by -44.5% in the last 24h. |
|
RxSight | March 31 Price is down by -5.2% in the last 24h. |
|
RxSight | March 27 Price is up by 7.3% in the last 24h. |
Alternative Data for RxSight
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 85 | Sign up | Sign up | Sign up |
| Webpage traffic | 7,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 18 | Sign up | Sign up | Sign up |
| Patents | 24 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 361 | Sign up | Sign up | Sign up |
| Facebook Followers | 651 | Sign up | Sign up | Sign up |
| Instagram Followers | 2,029 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 21 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 352 | Sign up | Sign up | Sign up |
| Twitter Followers | 241 | Sign up | Sign up | Sign up |
| Twitter Mentions | 83 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 796 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 63 | Sign up | Sign up | Sign up |
| Linkedin Employees | 383 | Sign up | Sign up | Sign up |
About RxSight
RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
| Price | $16.26 |
| Target Price | Sign up |
| Volume | 2,110,000 |
| Market Cap | $656M |
| Year Range | $16.21 - $56.56 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
 |
RxSight (NASDAQ:RXST) Given “Underperform” Rating at Bank of AmericaApril 5 - ETF Daily News |
|
RxSight (NASDAQ:RXST) Reaches New 52-Week Low Following Analyst DowngradeApril 4 - ETF Daily News |
 |
JP Morgan downgrades RxSight on market, competitive pressuresApril 4 - Yahoo |
|
RxSight, Inc. (NASDAQ:RXST) Receives $49.33 Average Target Price from AnalystsApril 3 - ETF Daily News |
|
Is RxSight, Inc. (NASDAQ:RXST) Trading At A 39% Discount?April 3 - Yahoo |
|
RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ...April 3 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 35M | 36M | 25M | -6.3M | -9.2M | -0.160 |
| Q2 '24 | 35M | 35M | 24M | -6.1M | -5.2M | -0.160 |
| Q1 '24 | 30M | 32M | 21M | -9.1M | -7.9M | -0.250 |
| Q4 '23 | 29M | 32M | 18M | -9.2M | -8.1M | -0.260 |
| Q3 '23 | 21M | 28M | 14M | -12M | -13M | -0.310 |
Insider Transactions View All
| Fountain Tamara filed to sell 24,793 shares at $25.7. March 13 '25 |
| Maniar Shweta filed to sell 7,383 shares at $30.9. January 27 '25 |
| Corley Jesse Anderson filed to buy 3,210 shares at $31.1. January 17 '25 |
| Corley Jesse Anderson filed to buy 1,443 shares at $31.2. January 17 '25 |
| Goldshleger Ilya filed to sell 42,246 shares at $46.1. December 3 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$89.7 0% | 63 |
 |
Edwards LifesciencesEW |
$69.36 0% | 32 |
 |
Intuitive SurgicalISRG |
$451.4 0% | 61 |
 |
MedtronicMDT |
$82.88 0% | 50 |
 |
StrykerSYK |
$345.8 0% | 56 |
Read more about RxSight (RXST) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of RxSight?
The Market Cap of RxSight is $656M.
What is the current stock price of RxSight?
Currently, the price of one share of RxSight stock is $16.26.
How can I analyze the RXST stock price chart for investment decisions?
The RXST stock price chart above provides a comprehensive visual representation of RxSight's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling RxSight shares. Our platform offers an up-to-date RXST stock price chart, along with technical data analysis and alternative data insights.
Does RXST offer dividends to its shareholders?
As of our latest update, RxSight (RXST) does not offer dividends to its shareholders. Investors interested in RxSight should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of RxSight?
Some of the similar stocks of RxSight are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.